These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 12755649)

  • 21. Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy.
    Nierenberg AA; Petersen TJ; Alpert JE
    J Clin Psychiatry; 2003; 64 Suppl 15():13-7. PubMed ID: 14658986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment resistance in unipolar depression: Is it an iatrogenic phenomenon caused by antidepressant treatment of patients with a bipolar diathesis?
    Sharma V
    Med Hypotheses; 2006; 67(5):1142-5. PubMed ID: 16797856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is duloxetine effective treatment for depression with atypical features?
    Stewart JW; Deliyannides DA; McGrath PJ
    Int Clin Psychopharmacol; 2008 Nov; 23(6):333-6. PubMed ID: 18854721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why the Hamilton Depression Rating Scale endures.
    Licht RW; Bech P
    Am J Psychiatry; 2005 Dec; 162(12):2394-5; author reply 2397-8. PubMed ID: 16330614
    [No Abstract]   [Full Text] [Related]  

  • 25. Atypical depression. A valid clinical entity?
    Stewart JW; McGrath PJ; Rabkin JG; Quitkin FM
    Psychiatr Clin North Am; 1993 Sep; 16(3):479-95. PubMed ID: 8415233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depression and mania in patients with epilepsy.
    Schmitz B
    Epilepsia; 2005; 46 Suppl 4():45-9. PubMed ID: 15938709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using treatment algorithms to bring patients to remission.
    Trivedi MH
    J Clin Psychiatry; 2003; 64 Suppl 2():8-13. PubMed ID: 12625793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depression in the medical setting: biopsychological interactions and treatment considerations.
    Evans DL; Staab JP; Petitto JM; Morrison MF; Szuba MP; Ward HE; Wingate B; Luber MP; O'Reardon JP
    J Clin Psychiatry; 1999; 60 Suppl 4():40-55; discussion 56. PubMed ID: 10086482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diagnosis and treatment of depression in the geriatric population.
    Khouzam HR
    Compr Ther; 2009; 35(2):103-14. PubMed ID: 19618759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project.
    Hennings JM; Owashi T; Binder EB; Horstmann S; Menke A; Kloiber S; Dose T; Wollweber B; Spieler D; Messer T; Lutz R; Künzel H; Bierner T; Pollmächer T; Pfister H; Nickel T; Sonntag A; Uhr M; Ising M; Holsboer F; Lucae S
    J Psychiatr Res; 2009 Jan; 43(3):215-29. PubMed ID: 18586274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.
    Arnold LM; Meyers AL; Sunderajan P; Montano CB; Kass E; Trivedi M; Wohlreich MM
    Ann Clin Psychiatry; 2008; 20(4):187-93. PubMed ID: 19034749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [When discontinue preventive treatment of recurrent depression?].
    Dalery J; Sermet E
    Encephale; 1995 Feb; 21 Spec No 1():59-61. PubMed ID: 7729359
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of imipramine in psychotic versus nonpsychotic depression.
    Birkenhager TK; van den Broek WW; Mulder PG; Moleman P; Bruijn JA
    J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression.
    Hollon SD; DeRubeis RJ; Shelton RC; Amsterdam JD; Salomon RM; O'Reardon JP; Lovett ML; Young PR; Haman KL; Freeman BB; Gallop R
    Arch Gen Psychiatry; 2005 Apr; 62(4):417-22. PubMed ID: 15809409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project.
    Trivedi MH; Rush AJ; Crismon ML; Kashner TM; Toprac MG; Carmody TJ; Key T; Biggs MM; Shores-Wilson K; Witte B; Suppes T; Miller AL; Altshuler KZ; Shon SP
    Arch Gen Psychiatry; 2004 Jul; 61(7):669-80. PubMed ID: 15237079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of antidepressant response in younger and older women.
    Grigoriadis S; Kennedy SH; Bagby RM
    J Clin Psychopharmacol; 2003 Aug; 23(4):405-7. PubMed ID: 12920418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time course of depression-symptom improvement during treatment with duloxetine.
    Hirschfeld RM; Mallinckrodt C; Lee TC; Detke MJ
    Depress Anxiety; 2005; 21(4):170-7. PubMed ID: 16035056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Major depressive disorder: remission of associated symptoms.
    Trivedi MH
    J Clin Psychiatry; 2006; 67 Suppl 6():27-32. PubMed ID: 16848674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed loss of efficacy and depressogenic action of antidepressants.
    Raja M
    J Clin Psychopharmacol; 2009 Dec; 29(6):612-4. PubMed ID: 19910735
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.